ALTSTATION.IO

Welltower Inc. (WELL) Stock Analysis

By Nova Skye | AltStation.io | Updated February 07, 2026

Price

$193.81

Change

+1.44%

Market Cap

$133.01B

Avg Volume

3.4M

Company Overview

Welltower Inc. specializes in real estate investment trusts (REITs), focusing primarily on healthcare facilities and senior housing. They provide rental properties and wellness communities catering to the needs of aging seniors across the U.S., U.K., and Canada. Their extensive portfolio includes over 2,000 properties designed to foster vibrant living environments for older adults, blending housing with hospitality.

Welltower is a market leader in the healthcare REIT sector, primarily due to its expansive portfolio and strategic location in attractive micro markets. Their edge comes from a data-driven approach to capital allocation and a robust operating model that enhances property performance. Competitive threats exist from companies like Healthpeak Properties and Ventas, which also target healthcare-related real estate. However, Welltower’s focus on senior living and wellness sets it apart in a growing market, especially as the aging population expands.

Currently, Welltower is in a growth phase, focusing on expanding its footprint in senior housing. The company’s recent strategic initiatives include optimizing its existing properties and investing in high-demand areas, which have shown healthy rental growth. Their disciplined approach and attention to operational excellence have positioned them well despite market challenges, underscoring their commitment to drive long-term shareholder value.

Key Financials

Market Cap

$133.01B

Revenue

$9.91B

EBITDA

$3.75B

Gross Margin

39.8%

Profit Margin

9.7%

Revenue Growth

30.6%

Total Cash

$6.81B

Total Debt

$18.17B

Free Cash Flow

-$2.74B

52-Week Price Performance Analysis

Price Statistics

P/E Ratio

133.66

Forward P/E

88.90

Beta

0.83

52-Week High

$209.05

52-Week Low

$130.29

EPS

$1.45

50-Day Avg

$190.57

200-Day Avg

$170.90

Price/Book

3.42

Technical Analysis

The overall trend for Welltower Inc. (WELL) over the past 52 weeks shows a strong upward movement, culminating in a 39.3% increase from around $139 in February to the current price of $193.81. Key resistance is noted near the $195 level, with the recent high reaching approximately $195.92, while support has been consistently established around $140, evidenced by multiple bounces off that level. A noticeable ascending channel pattern has formed, characterized by higher lows and higher highs, suggesting sustained positive momentum. In the past few weeks, the stock has exhibited solid upward momentum, particularly following a consolidation phase in late January, which has set the stage for a potential breakout above resistance. Currently priced at $193.81, WELL is hovering near its recent highs and is roughly 1.75% below the 52-week peak. This positioning implies bullish sentiment, with traders likely watching for a breakout above $195 to confirm further upward potential.

Recent News and Developments

Here’s a roundup of the latest news and developments for Welltower Inc

(WELL) stock from the past week (February 1-7, 2026):

### Analyst Ratings Remain Positive with Upgraded Price Targets
Welltower Inc

(WELL) continues to hold an average rating of “Moderate Buy” from brokerages, based on analyses from 15 firms. The consensus one-year average target price for the stock is $204.80. Several analysts have recently raised their price targets, including Scotiabank, which increased its target to $214.00. While the overall sentiment is positive, with 11 “buy” ratings and 1 “strong buy,” some analysts maintain “hold” (2) or “sell” (1) recommendations.

Market Update

### Upcoming Q4 2025 Earnings Anticipated
Welltower is scheduled to release its fourth-quarter 2025 financial results after the market closes on Tuesday, February 10, 2026, followed by a conference call and webcast on Wednesday, February 11, 2026. Analysts are anticipating quarterly earnings of $1.44 per share, which would signify a 27.4% increase year-over-year. Revenue forecasts for the quarter

Market Sentiment and Analyst Recommendations

Bull Case

Welltower is firing on all cylinders with 30.6% revenue growth and an expected 27.4% earnings beat in Q4 2025. The stock has crushed it over 52 weeks, up 39.3% from $139 to $193.81, and the ascending channel pattern shows sustained momentum with higher lows and higher highs. Analyst consensus is strong — 11 buy ratings and 1 strong buy with a $214.20 average target, implying 10.5% upside from current levels. The real story is the demographic tailwind in healthcare real estate. An aging population needs senior housing and care facilities, and Welltower owns the best properties in that space. At a $133B market cap with $6.81B in cash, the balance sheet can support continued M&A and dividend growth. The Q4 earnings call on February 11 should validate the growth trajectory and give management a platform to discuss acquisition pipeline.

Bear Case

The P/E of 133.66 is completely detached from reality. You’re paying $133 for every dollar of earnings, which means the market has priced in perfection and leaves zero room for execution stumbles. The debt load of $18.17B against $6.81B in cash is concerning — that’s a 2.67x net debt position that limits financial flexibility if interest rates stay elevated or acquisition returns disappoint. The UK regulatory scrutiny on the Barchester care home acquisitions is a real problem. The CMA investigation into HC-One and other deals could force divestitures or block future UK expansion, which matters if those markets were part of the growth thesis. At $195.92 near the 52-week high, you’re buying at peak sentiment with the stock already up 39% in a year. If Q4 earnings miss the 27.4% growth expectation or guidance softens, the multiple compression could be brutal at these valuations.

What to Watch

Q4 2025 earnings on February 11 are critical — watch for EPS hitting $1.44 and revenue at $2.71B. Any miss on either metric or softer 2026 guidance will trigger a sharp selloff given the valuation. The CMA investigation timeline matters significantly. If regulators block or delay the HC-One acquisition or force asset sales, it signals regulatory risk in international markets and could derail the acquisition strategy that’s driving growth. Monitor whether management maintains the 27%+ earnings growth guidance or pulls back expectations. Watch the $195 resistance level closely — a sustained break above $209 (the 52-week high) suggests the bull case is intact, but a rejection below $190 and consolidation could indicate the rally has run its course. Also track debt levels after Q4 results. If net debt climbs above 2.8x while interest rates remain sticky, refinancing costs could pressure margins and justify multiple compression even if growth stays strong.

Analyst Consensus

BUY

Based on 20 analyst opinions

Low Target

$172.00

Mean Target

$214.20

High Target

$260.00

Earnings and Financial Data

Sector

Real Estate

Industry

REIT – Healthcare Facilities

Employees

685

Earnings & Dividends

Next Earnings

Feb 10, 2026

EPS (Trailing)

$1.45

Dividend Yield

155.0%

Payout Ratio

189.7%

Frequently Asked Questions

Is WELL a good stock to buy?

Analysts are bullish on Welltower Inc. with a recommendation to buy and a price target of $214.20, suggesting significant upside potential from its current price of $193.81. The solid fundamentals in the healthcare REIT sector support this positive outlook.

What is WELL’s price target?

The consensus price target for Welltower Inc. is $214.20, implying a potential upside of about 10.5% from the current price of $193.81. This target reflects confidence from analysts in the company’s growth trajectory.

Does WELL pay a dividend?

Yes, Welltower Inc. offers a substantial dividend yield of 155.0%. This high yield makes it an attractive option for income-focused investors in the real estate sector.

What is the P/E ratio for WELL?

Welltower Inc. has a trailing P/E ratio of 133.66 and a forward P/E of 88.90. While the current P/E is high, the growth potential in the healthcare industry may justify this valuation.

What is the 52-week range for WELL?

The 52-week range for Welltower Inc. stock is between $130.29 and $209.05. This range indicates volatility but also a strong recovery potential as it approaches its high.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated February 07, 2026.